Mixed trend on the daily chart: below its 200-day average, above its 50-day · 50-day below the 200-day · SuperTrend up since Oct 12 · inside the Ichimoku cloud · RSI 56 · MACD above its signal
None of the 29 investors followed here reported a position in TTOO in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a TTOO trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for TTOO.
No analyst coverage for this instrument.
T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel. The company was incorporated in 2006 and is based in Lexington, Massachusetts.
No recent headlines.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -56.0 | 0.0 | -86.4 | 900.0 | -86.7 | 50.0 | -16.7 | 100.0 | -40.0 | 33.3 | −84.0% | ||
| 2025 | -48.8 | -41.9 | -1.6 | -6.5 | 40.0 | -13.6 | -87.1 | -77.8 | 210.0 | -11.3 | 10.0 | -58.7 | −98.8% |
| 2024 | -28.3 | 12.0 | -40.5 | 11.8 | 53.2 | 3.9 | -8.6 | -34.6 | -38.2 | -55.5 | -34.7 | -26.6 | −93.3% |
| 2023 | 10.6 | -60.8 | -25.2 | -28.3 | -72.7 | -21.6 | 108.9 | 112.2 | -29.4 | -73.2 | -40.1 | 77.3 | −95.6% |
| 2022 | -18.6 | 3.6 | 20.5 | -29.4 | -45.3 | -20.2 | -25.3 | 1.6 | -7.8 | 1537.2 | -10.3 | -14.5 | +175.1% |
| 2021 | 60.5 | 15.1 | -29.3 | -14.8 | 0.7 | -14.4 | -13.4 | -9.3 | -2.1 | -15.4 | -20.0 | -16.7 | −58.4% |
| 2020 | -23.9 | -22.5 | -5.8 | -16.0 | 53.9 | 51.3 | 30.7 | -6.0 | -12.8 | -1.5 | -17.2 | 11.7 | +6.0% |
| 2019 | 16.3 | 24.0 | -39.4 | -2.3 | -24.1 | -13.8 | -64.9 | 125.4 | 88.0 | -2.0 | -44.5 | -14.0 | −61.1% |
| 2018 | 20.1 | 6.1 | 23.6 | -1.1 | 15.4 | 4.5 | -22.6 | 9.0 | 14.1 | -29.5 | -15.4 | -32.2 | −26.9% |
| 2017 | 2.7 | 4.6 | -6.9 | -8.6 | -31.2 | -3.0 | -18.1 | 59.3 | 0.2 | -11.2 | 12.1 | -1.4 | −21.7% |
| 2016 | -18.9 | -9.9 | 23.4 | -7.0 | -6.0 | -8.5 | -28.3 | 17.3 | 9.0 | -12.7 | -7.8 | -9.8 | −51.9% |
| 2015 | 12.4 | -23.3 | -6.4 | -0.3 | 8.5 | -3.3 | -11.2 | -17.6 | -26.3 | 26.9 | 6.0 | -7.2 | −43.1% |
| 2014 | -22.1 | -10.7 | 11.0 | 7.4 | −17.1% |